HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.

7th Edition of Cardiology World Conference

October 08-10, 2026 | Tokyo, Japan

October 08 -10, 2026 | Tokyo, Japan

Cardio 2026

 Narendra Kumar, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Narendra Kumar, HeartbeatsZ Academy, United Kingdom

Background and rationale. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide and tirzepatide, consistently achieve 10–22% total body weight reduction in clinical trial populations; however, cross-sectional and longitudinal data increasingly dem [....] » Read More

Yochai Birnbaum, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Yochai Birnbaum, Baylor College of Medicine, United States

The original trials assessing the effects of thrombolytic therapy versus placebo included patients with compatible symptoms and were not restricted to patients with ST elevation. However, a meta-analysis that was published in Lancet in 1996 suggested that thrombolytic therapy red [....] » Read More

Yong Xiao Wang, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

Pulmonary hypertension (PH) is a common and serious lung disease, molecular mechanisms remain poorly understanded, and medications are neither always effective nor specific. In a series of our current studies, we have explored the potential important role of ryanodine receptor 2 [....] » Read More

Arthur J Siegel, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Arthur J Siegel, Massachusetts General Hospital, United States

Advances in primary cardiovascular prevention depend upon enhanced risk stratification. Gated coronary artery calcium CT scanning independently identifies persons at increased risk for major acute cardiac events including sudden death due to subclinical coronary atherosclerosis.& [....] » Read More

Md Aminul Haque, Speaker at Heart Conferences
Oral Presentation (In-Person)
Md Aminul Haque, Combined Military Hospital (CMH), Bangladesh

Background: Early revascularization is the cornerstone of management in ST-elevation myocardial infarction (STEMI), yet a substantial proportion of patients in resource-limited settings present beyond 24 hours, where the benefit of late percutaneous coronary intervention (PCI) re [....] » Read More

Sarsenbaeva Gulzhan, Speaker at Heart Conferences
Oral Presentation (In-Person)
Sarsenbaeva Gulzhan, Institute of Surgery, Kazakhstan

In domestic cardiac surgery, there is currently a trend towards an increasing incidence of complex, combined, and rare pathologies of the heart and blood vessels in children. The purpose of the report : to study rare congenital heart anomalies encountered in pediatric cardiac [....] » Read More

 Nguyen Nhat Dinh Ngo, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Nguyen Nhat Dinh Ngo, Hoan My Sai Gon Hospital, Vietnam

Background Situs inversus totalis is a rare congenital anomaly that poses unique challenges in electrocardiographic interpretation and the assessment of myocardial ischemia. While cardiac troponin elevation is commonly indicative of myocardial injury due to obstructive coronar [....] » Read More

Peipei Zhang, Speaker at Heart Conferences
Oral Presentation (In-Person)
Peipei Zhang, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, China

Background: Transthoracic echocardiography is the first-line test for congenital heart disease (CHD), but accurate screening and lesion subtyping require expertise and synthesis across multiple heterogeneous cine clips. We developed a video-based deep learning approach for examin [....] » Read More

Longcheng Liu, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Longcheng Liu, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Background: Inflammation is widely recognized as a central contributor to the pathogenesis and prognosis of repeat revascularization (RR) and in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Diabetes mellitus (DM) not only markedly increases the risk [....] » Read More

kwabena Sakyi, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
kwabena Sakyi, Ghana Standards Authority, Ghana

  Cardiovascular diseases remain one of the leading causes of death worldwide, with a growing burden in developing countries where access to specialized cardiac care is limited. This presentation explores the role of community-based interventions in improving heart health [....] » Read More

Joseph W Ellis, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Joseph W Ellis, American Whitewater Expeditions, United States

Sudden Cardiac Arrest (SCA) is a leading cause of preventable death globally, with survival declining 7–10% for every minute defibrillation is delayed. While advances in emergency medicine have improved outcomes, the first moments following an arrest remain critical—a [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Stem cell (SC)-based therapy has been considered as a promising option in the treatment of ischemic heart disease. The formation of new cardiomyocytes within the injured myocardium has not been conclusively demonstrated. Consequently, the focus of research in the field has since [....] » Read More

Moataz Taha Mahmoud, Speaker at Heart Conferences
Oral Presentation (In-Person)
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia

Background: Primary cardiac lymphomas (PCL) represent extremely rare cardiac tumors which are accompanied by poor prognosis, unless they are timely diagnosed and treated. Despite the rarity of Primary cardiac lymphomas, they should always be kept in mind in the differential diagn [....] » Read More

Vaibhav Roy, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Vaibhav Roy, Sharda University, India

Background: Immune checkpoint inhibitors (ICIs) significantly improve cancer outcomes but can cause rare, potentially fatal cardiotoxicity, including myocarditis and major adverse cardiovascular events (MACE). Machine learning (ML) and artificial intelligence (AI) models have eme [....] » Read More

Diana Carolina Alvarado Echeona, Speaker at Heart Conferences
Oral Presentation (In-Person)
Diana Carolina Alvarado Echeona, Universidad El Bosque, Colombia

Background: Cardiovascular disease remains a leading cause of disability worldwide, and cardiac rehabilitation (CR) programs play a crucial role in improving physical capacity, risk factor control, and overall patient well-being. However, evidence on short-term changes in health- [....] » Read More

Khalid Elhaj Mohamed Saeed, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Khalid Elhaj Mohamed Saeed, Abu Dhabi Health Services Company (SEHA), United Arab Emirates

Background: Cystic echinococcosis, or hydatid cystic disease, is a globally prevalent zoonotic infection that typically affects the liver or lungs. Case Summary: A 28-year-old man residing in the UAE presented with chronic hemoptysis, melena, and weight loss. Chest radiography [....] » Read More

Cassandra Elize P Flores, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Cassandra Elize P Flores, Veterans Memorial Medical Center, Philippines

The uric acid-to-albumin ratio (UAR) has been proposed as a composite biomarker reflecting inflammatory and oxidative pathways relevant to coronary artery disease (CAD).¹?² Prior studies have explored its association with CAD extent and cardiovascular disease.³?? T [....] » Read More

Meiza Azzahra, Speaker at Heart Conferences
Poster Presentation (In-Person)
Meiza Azzahra, Dr Soehadi Prijonegoro General Hospital, Indonesia

Background: Partial anomalous pulmonary venous drainage (PAPVD) is a rare congenital cardiovascular anomaly causing left-to-right shunting that may result in chronic right ventricular (RV) volume overload and pulmonary hypertension. Although commonly diagnosed in childhood, pa [....] » Read More

Devshankar Moosad EI, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Devshankar Moosad EI, Christian Medical College, India

Background: Cardiac rhabdomyoma is the most common primary cardiac tumor in infancy and is frequently associated with tuberous sclerosis complex (TSC). Case Summary: A 5-month-old asymptomatic infant presented with electrocardiography (ECG) showing marked ST-segment elevatio [....] » Read More

Moganapriya, Speaker at Heart Conferences
Poster Presentation (In-Person)
Moganapriya, Tan Tock Seng Hospital, Singapore

A 36-year-old woman with a significant history of Group 1 pulmonary arterial hypertension (PAH) with secondary to mixed connective tissue disease overlap syndrome (systemic lupus erythematosus and systemic sclerosis), presented with a one-week history of fever, nonproductive c [....] » Read More

 Snehasis Bhunia, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Snehasis Bhunia, Uttar Pradesh University of Medical Sciences, India

Arterial stiffness is a measure of how flexible and pliable the walls of the arteries are. It is an important indicator of cardiovascular health, as stiff arteries can lead to increased risk of developing cardiovascular diseases such as heart attack and stroke. One of the main f [....] » Read More

Eric Tran, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Eric Tran, University of California - Riverside, United States

Background: Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation for AF and is dependent on achieving durable electrical isolation of all pulmonary veins (PVs). Anatomical variations, such accessory PVs, are common and can lead to incomplete isolation and arrhyt [....] » Read More

Eric Tran, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Eric Tran, University of California - Riverside, United States

Background: Takotsubo cardiomyopathy (TCM) is a state of left ventricular (LV) dysfunction induced by a hypercatecholaminergic milieu, leading classically to apical dyskinesis with a compensatory hyperdynamic base. We present a case of sepsis-induced TCM complicated by torsades d [....] » Read More

Esha Mohamed Nisarahmed , Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Esha Mohamed Nisarahmed , M S Ramaiah University Of Applied Sciences, India

Introduction: Cardiac surgery remains a vital intervention for severe cardiovascular conditions. Despite advancements in surgical expertise and technology, postoperative complications—ranging from metabolic and hematologic disturbances to cardiovascular dysregulation— [....] » Read More

Abel Don Palayoor , Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Abel Don Palayoor , M.S Ramaiah University of Applied Sciences, India

Background: Cardiac complications remain a major source of perioperative morbidity and long-term dysfunction across modern cardiothoracic and interventional procedures. Despite advances in imaging, anaesthesia, and device technology, procedural cardiac risk is amplified by patien [....] » Read More

Faiza Bekakchi, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Faiza Bekakchi, Chu Setif, Algeria

Introduction: Myocardial ischemia is a major cause of cardiovascular morbidity and mortality, Early diagnosis is essential to optimize treatment and improve the prognosis, Stress echocardiography with dipyridamole, in particular the evaluation of coronary flow reserve, constitute [....] » Read More

Sekib Sokolovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina

Sudden cardiac death (SCD) among athletes has been increased in recent years. This high-impact event occurs from unrecognized structural or electrical heart disease in professional athletes, while in recreational sports happens in older athletes due to occult coronary artery dise [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). In this context, the need for innovative heart disease treatments has become critical since the diseases remain the world&r [....] » Read More

Wang Jiale, Speaker at Cardiovascular Conference
Oral Presentation
Wang Jiale, Fuwai Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, China

Objective The C-Reactive protein-triglyceride glucose index (CTI) serves as a dependable proxy for both inflammatory status and insulin resistance, demonstrating an independent association with various clinical presentations of coronary artery disease. This research sought to ass [....] » Read More

Wang Jiale, Speaker at Cardiovascular Conference
Oral Presentation
Wang Jiale, Fuwai Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, China

Background The current cardiovascular risk assessment system has not fully integrated the interaction between atherosclerotic promoting factors and protective factors. Lipoprotein(a) [Lp(a)], an independent risk factor for coronary heart disease, has a pathogenic risk that may be [....] » Read More

 Alisha Varia, Speaker at Cardiology Conferences
Oral Presentation
Alisha Varia, University of Liverpool School of Medicine, United Kingdom

Background: Guidelines recommend patent foramen ovale (PFO) closure for secondary prevention after cryptogenic stroke in patients aged 18-65 years, but there is limited evidence to guide management of older adults. This research aims to assess the efficacy, safety and methodologi [....] » Read More

Panpan Hao, Speaker at Cardiology Conferences
Oral Presentation
Panpan Hao, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, Shandong, China

BACKGROUND: The hyperproliferation of smooth muscle cells and deposition of collagen in the pulmonary artery are among the primary characteristics of pulmonary hypertension (PH). These processes contribute to vascular remodeling, ultimately leading to elevated pulmonary artery pr [....] » Read More

Ahmed Elaraby, Speaker at Heart Conferences
Oral Presentation (In-Person)
Ahmed Elaraby, Faculty Of Medicine, Al-Azhar University, Egypt

Background: Coronary artery disease remains a leading cause of global mortality. Although angiography-guided percutaneous coronary intervention (PCI) is the standard approach, it has limitations in visualizing plaque morphology, vascular remodeling, atherosclerotic burden, and ca [....] » Read More

Reiva Geen Cabaling, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Reiva Geen Cabaling, BAGUIO GENERAL HOSPITAL AND MEDICAL CENTER, Philippines

Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain significant causes of pediatric morbidity in low-resource settings. Local data on clinical profiles and outcomes in the Philippines remain limited, underscoring the need for updated institutional evidence. This [....] » Read More

Naomi Gudu, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Naomi Gudu, Mamlaka Medical Center, Kenya

Background: AL (light-chain) amyloidosis is a rare multisystem disorder caused by extracellular deposition of monoclonal immunoglobulin light chains, leading to progressive organ dysfunction. Cardiac involvement is the strongest predictor of mortality and often presents with [....] » Read More

Umar Badshah, Speaker at Heart Conferences
Oral Presentation (In-Person)
Umar Badshah, Saidu Teaching Hospital, Pakistan

Objectives: To determine the frequency and identify the determinants of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography and/or percutaneous  coronary intervention (PCI) in a  tertiary care hospital in rural Pakistan. Methodology: This [....] » Read More

Rahul Hajare, Speaker at Heart Conferences
Oral Presentation (In-Person)
Rahul Hajare, Sandip University, India

Post COVID-19 pulmonary assessment revealed a persistent decrease in maximal oxygen consumption (VO? max) among previously symptomatic individuals. A proportion of patients particularly those with severe disease or ARDS exhibited reduced diffusion capacity for carbon monoxide (DL [....] » Read More

Jibran, Speaker at Heart Conferences
Oral Presentation (In-Person)
Jibran, Jinnah University for Women, Karachi, Pakistan, Pakistan

Heart care is changing fast. New devices and digital tools are improving how we diagnose and treat heart disease. Combination products are also becoming more common. These innovations bring real hope to patients. But they also create regulatory challenges. Many promising technol [....] » Read More

Prashant Sakharam Bhokardankar , Speaker at Heart Conferences
Oral Presentation (Virtual)
Prashant Sakharam Bhokardankar , Datta Meghe Ayurvedic Medical College, India

The incidence of cardiovascular diseases (CVDs) has greatly risen in recent years because of environmental shifts, unhealthy diets, and changes in lifestyle. Consequently, the term "hridroga," which pertains to heart-related ailments in Ayurveda, has gained prominence. [....] » Read More

 Franz Porzsolt, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Franz Porzsolt, Private Research Institute Clinical Economics, Germany

The individual risk profile of the patient and the health added value of the interventions define the affordability of health care. 1. The re-allocation of resources guarantees the financial viability of healthcare. 2. Re-allocation is based on evidence of objective proof o [....] » Read More

 Daniel Bradach, Speaker at Heart Conferences
Oral Presentation (Virtual)
Daniel Bradach, St. George’s University School of Medicine, Grenada

Sickle cell disease and thalassemia syndromes are increasingly recognized as chronic multisystem disorders, with cardiovascular (CV) sequelae representing a significant proportion of long-term morbidity and mortality. Survival has improved considerably due to the better transfusi [....] » Read More

Apoorva Tripathi, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Apoorva Tripathi, Oxford University Hospitals, United Kingdom

Background: Polysplenia syndrome, a rare form of left isomerism, usually presents in childhood with severe cardiac anomalies. Adult presentation with a structurally normal heart is uncommon. Case Presentation: A 26-year-old male presented with recurrent syncope over one year. [....] » Read More

Jeyatheepan Jeyaretnam, Speaker at Heart Conferences
Oral Presentation (Virtual)
Jeyatheepan Jeyaretnam, Lymph-Flow, Germany

The lymphatic system is a fundamental yet underrecognized component of cardiovascular regulation, immune homeostasis, and metabolic balance. Lymphatic dysfunction contributes to chronic inflammation, endothelial impairment, venous hypertension, and interstitial fluid overload, th [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Rationale: Diagnosis of ST-segment elevation myocardial infarction in the presence of left bundle branch block (LBBB) is challenging and infarction equivalent. Therefore, the intravenous infusion of a thrombolytic may be a crucial step. Emergent Sgarbosa criteria and their modifi [....] » Read More

Phoebe Wamalwa, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Phoebe Wamalwa, Ministry of Health, Kenya

Background: Type 1 diabetes (T1D) is rising globally, with a disproportionate burden of complications in developing countries. In such settings, a 10-year-old diagnosed with T1D has an average life expectancy of only 13 years, five times lower than in high-income countries. Adver [....] » Read More

Jong Hoon Koh, Speaker at Cardiology Conferences
Poster Presentation
Jong Hoon Koh, Seoul Seonam Hospital, Korea, Republic of

Background: N-terminal pro-B type natriuretic peptide (NT-proBNP) has been introduced as a useful parameter for assessing left ventricular (LV) function. We aimed to evaluate correlation between NT proBNP on the LV systolic and diastolic echocardiographic parameters in mid-range [....] » Read More

Jong Hoon Koh, Speaker at Cardiology Conferences
Poster Presentation
Jong Hoon Koh, Seoul Seonam Hospital, Korea, Republic of

Background: Prolonged corrected QT (QTc) interval is associated with an increased risk of cardiovascular mortality and sudden cardiac death. We sought to investigate whether 24-hour (h) ambulatory blood pressure (ABP) profiles and echocardiographic findings with QTc prolongation [....] » Read More

Parinaz Mohammadi, Speaker at Cardiology Conferences
Poster Presentation
Parinaz Mohammadi, Tabriz University of Medical Sciences, Iran, Iran (Islamic Republic of)

In 2026, artificial intelligence (AI) has emerged as an indispensable co-pilot in cardiology, fundamentally transforming the management of cardiovascular diseases through enhanced precision diagnosis, optimized clinical trials, and proactive prevention strategies. The rapid integ [....] » Read More

Ermiyas Berehanu Hayle, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Ermiyas Berehanu Hayle, Hallelujah General Hospital, Ethiopia

Dilated cardiomyopathy (DCM) is one of the most important causes of heart failure and premature death globally, yet its burden is far from uniform. In developing nations—where diagnosis is often delayed, access to specialized cardiac care is limited, and multiple overlappin [....] » Read More

Jonsi Tavethia, Speaker at Heart Conferences
Poster Presentation (Virtual)
Jonsi Tavethia, B J Medical college, Ahmedabad, India

Heterotaxy syndrome is a rare congenital disorder characterized by abnormal arrangement of thoracoabdominal organs and complex cardiovascular malformations. Left isomerism, a subtype, typically features bilateral left atrial appendages, polysplenia, and interrupted inferior vena [....] » Read More

 Davor Horvat, Speaker at Heart Conferences
Poster Presentation (Virtual)
Davor Horvat, General Hospital, , Croatia (Hrvatska)

In our review, we wanted to highlight the advantages of implanting cardiac pacemakers on the right side of the chest, with the generator site below the right clavicle. This approach is not used as often as a method of implanting cardiac pacemakers today, but it has its advantages [....] » Read More

Meera Gopinath, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Meera Gopinath, Cardiff University Medical School, United Kingdom

Background: Atrial Septal Defects (ASDs) are common congenital heart defects, affecting nearly 25% of children. Larger ASDs may require device closure to prevent complications such as pulmonary hypertension and hypoxia. Evidence on long-term outcomes and adverse events after clos [....] » Read More

Aina Jarillo, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico

This case study integrates the relationship between connective tissue dysfunction and the formation of aortic aneurysms, emphasizing the molecular basis and its clinical expression. These types of disorders, mainly represented by Marfan and Loeys-Dietz syndromes, are he [....] » Read More

Ahmed Ahmed Mohamed Hassan, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Ahmed Ahmed Mohamed Hassan, Al-Azhar Medical School, Egypt

Background: Ventricular premature complex (VPC) is one of the most common ventricular arrhythmias and is strongly associated with heart failure (HF), all-cause hospitalization, and cardiovascular hospitalization Patients and Methods: Fifty-eight patients with ventricular extra [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a cornerstone in managing type 2 diabetes (T2D) and obesity, demonstrating benefits that extend far beyond glycaemic control. Initially developed for metabolic regulation, several large-scale cardiovascular out [....] » Read More

Mekhman N Mamedov, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation

Diabetes Mellitus (DM) has become a global epidemic. Its prevalence is increasing and is becoming younger among adults. Although type 2 diabetes accounts for the majority of diabetes, type 1 diabetes is also increasing. Patients with DM often have complex coronary anatomy, compli [....] » Read More

Johan, Speaker at Cardiovascular Conference
Oral Presentation
Johan, Greenfield University, United States

Title: Beyond Mechanical Revascularization: Intra-Plaque Integration of Nanoparticle-Coated PCSK9 Inhibitors, DMARDs, and APOC-3 siRNA as a Synergistic Triple-Target Strategy for Vulnerable Plaque Stabilization Background: Despite the success of percutaneous coronary interv [....] » Read More

Johan, Speaker at Cardiovascular Conference
Oral Presentation
Johan, Greenfield University, United States

Title: Beyond the Horizon: TIGR-Tas In Vivo Gene Editing Utilizing microRNA and Non-Coding RNA for No-Option Terminal Heart Failure Background: Patients with terminal heart failure who have failed pharmacological therapy and mechanical circulatory support (ICD, LVAD, CRT-D) [....] » Read More

Monisha D Souza, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Monisha D Souza, GOVERNMENT MEDICAL COLLEGE KOZHIKODE, India

INTRODUCTION: Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant vascular disorder characterized by mucocutaneous telangiectasia and arteriovenous malformations (AVMs). Pulmonary arterial hypertension (PAH) is an uncommon manifestation with an aggressive cou [....] » Read More

Monisha D Souza, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Monisha D Souza, GOVERNMENT MEDICAL COLLEGE KOZHIKODE, India

  Introduction: Infective Endocarditis affecting the Mitral-Aortic Inter-valvular Fibrosa (MAIF) is uncommon but clinically significant, as its avascular nature and subtle imaging features frequently lead to delayed recognition.   Case Report: A 47-year-old hyp [....] » Read More

Monisha D Souza, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Monisha D Souza, GOVERNMENT MEDICAL COLLEGE KOZHIKODE, India

Introduction Stent loss during percutaneous coronary intervention (PCI) is a rare but serious complication, particularly in primary PCI where thrombus burden, vessel tortuosity, and suboptimal lesion preparation increase procedural risk. Embolized stents can cause major vascul [....] » Read More

Joao Rafael De Oliveira Rocha Da Silva, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Joao Rafael De Oliveira Rocha Da Silva, Connect Life Rehabilitation and Performance, Brazil

Chronic pain is associated with the leading cause of disability in the world, just as cardiovascular diseases represent the highest incidence of death in the world. Both pathologies generate a high demand for health services and represent a high global population risk. In previou [....] » Read More

Andrey Belousov, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Andrey Belousov, Kharkiv National Medical University, Ukraine

A decrease in erythrocyte electrophoretic mobility serves as an important diagnostic marker of pathological conditions associated with impaired gas exchange, microcirculation, and tissue trophism, often leading to systemic hypoxia and deterioration of the patient's clinical s [....] » Read More

 Ruth Rasmussen, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Ruth Rasmussen, Liberty University, United States

Purpose: The objective of this study was to assess differences in dietary behavior and clinical risk factor outcomes and explore predictors of change among patients participating in traditional and Pritikin intensive cardiac rehabilitation (CR). Methods:  This secondary a [....] » Read More

 Amanda Tan Wei Zhen, Speaker at Heart Conferences
Oral Presentation (Virtual)
Amanda Tan Wei Zhen, Prince Charles Hospital, United Kingdom

Valvular heart disease (VHD) remains a major and growing cause of cardiovascular morbidity and mortality, particularly in ageing populations. The recent ESC/EACTS 2025 Guidelines provide an updated, evidence-based framework for the diagnosis, risk stratification, and management o [....] » Read More

Steve Cohen, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Steve Cohen, Medvesta Hypnosis Healthcare, NSA Illinois, United States

This keynote highlights how movement as medicine supports the goals of the Cardiology World Conference 2026 by emphasizing innovative, preventive approaches to heart health. For cardiologists, cardiovascular surgeons, researchers, healthcare practitioners, academicians, industry [....] » Read More

Zin Thandar Win, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Zin Thandar Win, University of California, Riverside, United States

Background: Thyrotoxic periodic paralysis (TPP) is a rare but potentially fatal manifestation of hyperthyroidism characterized by sudden hypokalemic paralysis. Excess thyroid hormone stimulates the Na?/K?-ATPase pump, causing rapid intracellular potassium shifts and severe hypok [....] » Read More

 Waqas Ghulam Hussain, Speaker at Heart Conferences
Poster Presentation (Virtual)
Waqas Ghulam Hussain, Higher Education Department, Pakistan

This study evaluates the impact of the recently developed BSSI on diabetic adults in Pakistan. A comparative analysis was conducted between BSSI, body mass index (BMI), and body surface area (BSA) to assess the performance of BSSI and identify ideal measures that can accurately p [....] » Read More

 Waqas Ghulam Hussain, Speaker at Heart Conferences
Poster Presentation (Virtual)
Waqas Ghulam Hussain, Higher Education Department, Pakistan

Establishing growth charts is one of the most important steps in establishing normal development standards and identifying possible patterns in human growth. The purpose of this study is to examine how well body surface area (BSA) and quantile regression (QR) percentiles perform [....] » Read More

Watsapp